We are urgently seeking 500 new Life Defenders (monthly supporters) before the end of October to help save babies from abortion 365 days a year. Your first gift as a Life Defender today will be DOUBLED. Click here to make your monthly commitment.
Pharmaceutical company seeks approval for Japan’s first abortion pill
Pharmaceutical company Linepharma International said it plans to seek approval for Japan’s first abortion pill next month, according to The Japan Times.
Linepharma received its pharmaceutical license in Japan in July and ran trials on the use of two drugs — mifepristone and misoprostol — to kill preborn children early in pregnancy. These trials were deemed “successful” in that they met their goal, which was to end pregnancies by ending the lives of human beings in utero. Linepharma believes the abortion pill regimen, which uses the same drugs as the abortion pill regimen in the United States, will be approved in Japan within a year.
Abortion is legal in Japan until 22 weeks, according to Japan Truly, through surgical abortion only. After 22 weeks, abortion is permissible if the mother’s life is considered to be under threat. However, intentionally killing a preborn child is never medically necessary. The consent of the baby’s father is required for a woman to have an abortion unless proof can be given that the father is missing or deceased or the pregnancy was the result of rape. However, according to Japan Truly, the abortion facility never actually verifies who the father is but simply accepts the consent form the woman provides. There are about 300,000 abortions in Japan each year, according to The Japan Times.
Linepharma claims that successfully killing innocent human beings in their earliest stages of development using the abortion pill is a win, but Linepharma is profiting from the deaths of preborn children and the desperation of women. And while doing so, it puts women’s health and lives at risk as well.
Every day in America, more than 2,800 preborn babies lose their lives to abortion.
That number should break our hearts and move us to action.
Ending this tragedy requires daily commitment from people like you who refuse to stay silent.
Millions read Live Action News each month — imagine the impact if each of us took a stand for life 365 days a year.
Right now, we’re urgently seeking 500 new Life Defenders (monthly donors) to join us before the end of October. And thanks to a generous $250,000 matching grant, your first monthly gift will be DOUBLED to help save lives and build a culture that protects the preborn.
Will you become one of the 500 today? Click here now to become a Live Action Life Defender and have your first gift doubled.
Together, we can end abortion and create a future where every child is cherished and every mother is supported.
The abortion pill has been found to be four times more dangerous for women than first-trimester surgical abortion and carries the risks of incomplete abortion, infection, hemorrhaging, and death.
A 2015 study found that among the abortions reviewed, the complication rate was 5.2% for women who took the abortion pill compared to 1.3% for first-trimester surgical abortions. When reviewing the abortions that resulted in “major complications,” researchers discovered that severe complications occurred for the abortion pill at a rate of .31% compared to .16% for first-trimester surgical abortions. Yet the abortion industry claims that the abortion pill is as safe as Tylenol.
A preborn child has a beating heart just 23 days after fertilization and the abortion pill works to deprive that growing child of nutrients before forcing her out of her natural environment in her mother’s womb. Some women have spoken of the trauma of seeing their baby’s body after the abortion is complete. If Linepharma is successful, more women in Japan may have the same traumatizing experience.
Live Action News is pro-life news and commentary from a pro-life perspective.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
Abortion Pill·By Nancy Flanders
